Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice

被引:40
作者
Papinska, A. M. [1 ]
Mordwinkin, N. M. [1 ]
Meeks, C. J. [1 ]
Jadhav, S. S. [1 ]
Rodgers, K. E. [1 ]
机构
[1] Univ So Calif, Sch Pharm, Los Angeles, CA 90033 USA
基金
美国国家卫生研究院;
关键词
NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; DIABETIC-NEPHROPATHY; CONCISE GUIDE; HEART; PHARMACOLOGY; EXPRESSION; MOBILIZATION; INFLAMMATION;
D O I
10.1111/bph.13225
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND AND PURPOSE Diabetic patients are at an increased risk of cardiovascular disease, in part due to inflammation and oxidative stress. These two pathological mechanisms also affect other organs and cells including the kidneys and progenitor cells. Angiotensin-(1-7) [Ang-(1-7)] has previously been shown to counterbalance pathological effects of angiotensin II, including inflammation and oxidative stress. The aim of this study was to investigate the effects of short-term (2 weeks) Ang-(1-7) treatment on cardiovascular and renal function in a mouse model of type 2 diabetes (db/db). EXPERIMENTAL APPROACH Eight- to nine-week-old db/db mice were administered either vehicle, Ang-(1-7) alone, or Ang-(1-7) combined with an inhibitor (losartan, PD123319, A-779, L-NAME or icatibant) daily for 14 days. KEY RESULTS An improvement in physiological heart function was observed in Ang-(1-7)-treated mice. Ang-(1-7) also reduced cardiomyocyte hypertrophy, fibrosis and inflammatory cell infiltration of the heart tissue and increased blood vessel number. These changes were blocked by antagonists of the MAS1, AT(2) and bradykinin receptors and inhibition of NO formation. Treatment with Ang-(1-7) reduced glomerular damage and oxidative stress in kidney tissue. Bone marrow and circulating endothelial progenitors, as well as bone marrow mesenchymal stem cells, were increased in mice treated with Ang-(1-7). CONCLUSIONS AND IMPLICATIONS Short-term Ang-(1-7) treatment of young db/db mice improved heart function and reduced kidney damage. Treatment also improved bone marrow and circulating levels of endothelial and mesenchymal stem cells. All of this may contribute to improved cardiovascular and renal function.
引用
收藏
页码:4443 / 4453
页数:11
相关论文
共 50 条
[21]   Beneficial effects of candesartan, an angiotensin II type I receptor blocker, on β-cell function and morphology in db/db mice [J].
Shao, Jiaqing ;
Iwashita, Noseki ;
Ikeda, Fuki ;
Ogihara, Takeshi ;
Uchida, Toyoyoshi ;
Shimizu, Tomoaki ;
Uchino, Hiroshi ;
Hirose, Takahisa ;
Kawamori, Ryuzo ;
Watada, Hirotaka .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 344 (04) :1224-1233
[22]   Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade [J].
Sukumaran, Vijayakumar ;
Tsuchimochi, Hirotsugu ;
Tatsumi, Eisuke ;
Shirai, Mikiyasu ;
Pearson, James T. .
BIOCHEMICAL PHARMACOLOGY, 2017, 144 :90-99
[23]   Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice [J].
Yang, Jianmin ;
Sun, Yu ;
Dong, Mei ;
Yang, Xiaoyan ;
Meng, Xiao ;
Niu, Rongrong ;
Guan, Juan ;
Zhang, Yun ;
Zhang, Cheng .
ATHEROSCLEROSIS, 2015, 240 (02) :544-549
[24]   Age-related changes in vascular responses to angiotensin-(1-7) in female mice [J].
Costa-Fraga, Fabiana P. ;
Goncalves, Gleisy K. ;
Souza-Neto, Fernando P. ;
Reis, Adelina M. ;
Capettini, Luciano A. S. ;
Santos, Robson A. S. ;
Fraga-Silva, Rodrigo A. ;
Stergiopulos, Nikolaos ;
da Silva, Rafaela F. .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2018, 19 (03)
[25]   Angiotensin-(1-7) relieved renal injury induced by chronic intermittent hypoxia in rats by reducing inflammation, oxidative stress and fibrosis [J].
Lu, W. ;
Kang, J. ;
Hu, K. ;
Tang, S. ;
Zhou, X. ;
Yu, S. ;
Xu, L. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2017, 50 (01)
[26]   Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic stroke [J].
Bennion, Douglas M. ;
Jones, Chad H. ;
Donnangelo, Lauren L. ;
Graham, Justin T. ;
Isenberg, Jacob D. ;
Dang, Alex N. ;
Rodriguez, Vermali ;
Sinisterra, Ruben D. M. ;
Sousa, Frederico B. ;
Santos, Robson A. S. ;
Sumners, Colin .
EXPERIMENTAL PHYSIOLOGY, 2018, 103 (06) :916-923
[27]   The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice [J].
Meneses, Carla ;
Gabriela Morales, Maria ;
Abrigo, Johanna ;
Simon, Felipe ;
Brandan, Enrique ;
Cabello-Verrugio, Claudio .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2015, 467 (09) :1975-1984
[28]   Oral administration of angiotensin-(1-7) decreases muscle damage and prevents the fibrosis in rats after eccentric exercise [J].
Totou, Nadia Lucia ;
de Moura, Samara Silva ;
Dias Martins Junior, Francisco de Assis ;
de Sousa, Frederico Barros ;
Coelho, Daniel Barbosa ;
de Oliveira, Emerson Cruz ;
Souza Dos Santos, Robson Augusto ;
Becker, Lenice Kappes ;
de Lima, Wanderson Geraldo .
EXPERIMENTAL PHYSIOLOGY, 2021, 106 (08) :1710-1719
[29]   Oral formulation angiotensin-(1-7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase [J].
Bastos, Aline Candida ;
Magalhaes, Giselle Santos ;
Gregorio, Juliana Fabiana ;
Matos, Natalia Alves ;
Motta-Santos, Daisy ;
Bezerra, Frank Silva ;
Souza Santos, Robson Augusto ;
Campagnole Santos, Maria Jose ;
Rodrigues-Machado, Maria Gloria .
IMMUNOBIOLOGY, 2020, 225 (02)
[30]   ACE2: Angiotensin II/Angiotensin-(1–7) Balance in Cardiac and Renal Injury [J].
Jasmina Varagic ;
Sarfaraz Ahmad ;
Sayaka Nagata ;
Carlos M. Ferrario .
Current Hypertension Reports, 2014, 16